These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7774031)
21. Solid self-microemulsifying drug delivery system of ritonavir. Deshmukh A; Kulkarni S Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049 [TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
23. Preformulation study of fiber formation and formulation of drug-loaded microfiber based orodispersible tablets for in vitro dissolution enhancement. Szabó P; Kállai-Szabó B; Sebe I; Zelkó R Int J Pharm; 2014 Dec; 477(1-2):643-9. PubMed ID: 25448565 [TBL] [Abstract][Full Text] [Related]
24. Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin. Li X; Zhi F; Hu Y Int J Pharm; 2007 Jan; 328(2):177-82. PubMed ID: 16978809 [TBL] [Abstract][Full Text] [Related]
25. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation. Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324 [TBL] [Abstract][Full Text] [Related]
26. Dissolution and bioavailability of the anhydrate and trihydrate forms of ampicillin. Hill SA; Jones KH; Seager H; Taskis CB J Pharm Pharmacol; 1975 Aug; 27(8):594-8. PubMed ID: 239175 [TBL] [Abstract][Full Text] [Related]
27. Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations. Wardrop J; Law D; Qiu Y; Engh K; Faitsch L; Ling C J Pharm Sci; 2006 Nov; 95(11):2380-92. PubMed ID: 16892210 [TBL] [Abstract][Full Text] [Related]
28. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations. Sawant KK; Patel MH; Patel K Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349 [TBL] [Abstract][Full Text] [Related]
29. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules. Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518 [TBL] [Abstract][Full Text] [Related]
30. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations. Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923 [TBL] [Abstract][Full Text] [Related]
31. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y; Kostewicz ES; Sheu MT; Dressman JB Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116 [TBL] [Abstract][Full Text] [Related]
32. [Enhancing of drug bioavailability using liquisolid system formulation]. Gajdziok J; Vraníková B Ceska Slov Farm; 2015 Jun; 64(3):55-66. PubMed ID: 26400228 [TBL] [Abstract][Full Text] [Related]
33. New nano-matrix oral formulation of nanoprecipitated cyclosporine A prepared with multi-inlet vortex mixer. Suzuki H; Hamao S; Seto Y; Sato H; Wong J; Prud'homme RK; Chan HK; Onoue S Int J Pharm; 2017 Jan; 516(1-2):116-119. PubMed ID: 27845213 [TBL] [Abstract][Full Text] [Related]
34. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients. Wikström H; Carroll WJ; Taylor LS Pharm Res; 2008 Apr; 25(4):923-35. PubMed ID: 17896097 [TBL] [Abstract][Full Text] [Related]
35. Structural characterisation and dehydration behaviour of siramesine hydrochloride. Zimmermann A; Tian F; de Diego HL; Frydenvang K; Rantanen J; Elema MR; Hovgaard L J Pharm Sci; 2009 Oct; 98(10):3596-607. PubMed ID: 19156865 [TBL] [Abstract][Full Text] [Related]
36. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
37. Solubility and intrinsic dissolution rate of alprazolam crystal modifications. Laihanen N; Muttonen E; Laaksonen M Pharm Dev Technol; 1996 Dec; 1(4):373-80. PubMed ID: 9552321 [TBL] [Abstract][Full Text] [Related]
38. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Patel GV; Patel VB; Pathak A; Rajput SJ Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843 [TBL] [Abstract][Full Text] [Related]